ONC Q1 2025 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q1 2025 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$1.1B+48.6% YoY

Gross Profit

$952M85.2% margin

Operating Income

$11M1.0% margin

Net Income

$1M0.1% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

-0.9%

Cash Flow

Operating Cash Flow

$44M

Free Cash Flow

-$72M

Stock-Based Comp.

$95M

Balance Sheet

Total Assets

$5.8B

Total Liabilities

$2.3B

Stockholders' Equity

$3.5B

Cash & Equivalents

$2.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$752M	+48.6%
Gross Profit	$952M	$627M	+51.9%
Operating Income	$11M	-$261M	+104.2%
Net Income	$1M	-$251M	+100.5%

Revenue Segments

Product

$1.4B99%

Collaboration

$9M1%

Geographic Segments

UNITED STATES

$567M51%

CHINA

$400M36%

Europe

$119M11%

All Other Countries Except China And United States Of America

$32M3%